Keysight Technologies

▲ Bull Case

• ◆AI data center test is a structural, 3–5 year demand wave decoupled from the semiconductor capex cycle. Every AI accelerator generation (NVL72 → NVL96 → Rubin → Blackwell Ultra) requires complete re-validation of high-speed electrical interfaces; 400G→800G→1.6T transitions generate instrument replacement cycles every 18–24 months regardless of macro conditions. This demand tracks hyperscaler AI capex, growing 25–35% annually.
• ◆6G pre-standard R&D is pulling forward 2–3 years earlier than consensus projects, with Keysight uniquely positioned as the measurement standard-setter. Q1 FY2026 CSG commercial communications +33% YoY is partially 6G-driven; Keysight is co-authoring ITU/3GPP sub-THz measurement frameworks. If 6G commercial orders begin in H2 FY2027 — one year ahead of consensus — FY2027–FY2028 EPS of ~$9–10 becomes ~$11–12, supporting a 25x re-rating toward $275–300.
• ◆Spirent revenue synergies materially exceed the cost synergy guidance and are completely unmodeled. Management's $100M synergy target is predominantly cost-based. The revenue opportunity — cross-selling Spirent's network test software subscriptions into Keysight's 40,000+ instrument customers, and Keysight instruments into Spirent's telco accounts — could dwarf cost synergies: potential 30–40% revenue expansion within existing footprint with no incremental acquisition cost.

▼ Bear Case

• ◆The current order surge is deferred capex catch-up, not structural demand — an AI capex pause in H2 FY2026 creates an air pocket before 6G commercial orders arrive. FY2024's trough was preceded by similarly strong orders; the current $2.8B backlog may predominantly reflect orders placed ahead of tariff uncertainty. If hyperscaler AI capex decelerates and 6G orders don't arrive until FY2028–FY2029, revenue stalls in the $6.0–6.3B range and the market re-rates to 18–19x on $8–9 EPS — implying $144–171, a -17% to -27% drawdown.
• ◆China export control expansion targeting sub-THz instruments is a binary tail risk that could crystallize rapidly and permanently. Keysight's instruments above 67 GHz are not currently classified as controlled equipment — but this classification can change with BIS rulemaking. If sub-THz systems are added to controlled lists, Keysight loses direct access to ~15–20% of revenue from Chinese domestic telecom makers and aerospace institutions, with no viable substitution strategy.
• ◆Spirent integration fails to deliver synergies, sustains margin compression, and creates goodwill impairment risk. At 2.4x EV/Revenue paid, Spirent was expensive. Network test software subscriptions are relationship-dependent: if key Spirent teams depart and customer relationships churn, the $100M synergy target is missed, operating margins remain at 15–17% vs. 22–25% pre-acquisition, and the $3.5B+ goodwill becomes vulnerable to impairment testing.

“The core disagreement: Is Keysight's FY2026 acceleration a structural multi-year growth inflection, or a one-time catch-up from FY2024–FY2025 deferred capex that will decelerate sharply in FY2027? Bull side (majority, ~10–12 of 14–16 analysts at Buy/Outperform): The convergence of AI data center test, 6G pre-standard R&D, Spirent network assurance, and advanced semiconductor node ramp creates a distinct new S-curve separable from prior wireless capex cycles. Sustained double-digit revenue growth through FY2028 + operating leverage + Spirent accretion → EPS of $11–12+ → 25–30x P/E appropriate. Bear side (minority, 3–5 analysts): Post-5G capex recovery cycles are historically followed by 18–24 month digestion periods. AI test demand is concentrated in 5–6 hyperscaler accounts with binary capex timing; the $2.8B backlog includes significant tariff pull-forward. FY2026 growth of 20–25% decelerates to 3–6% in FY2027, compressing the multiple to 18–20x on $8–9 EPS. Resolution timeline: The debate will be settled by (1) sustained quarterly orders above $1.5B for 3–4 consecutive quarters; (2) Spirent synergy realization in FY2026 P&L; (3) FY2027 guidance initiation at December 2026 annual earnings.”

• ◆Q2 FY2026 earnings confirmation of guidance ($1.69–1.71B revenue) and second consecutive record orders print (May/June 2026) — watch for orders ≥$1.5B and book-to-bill direction
• ◆Spirent synergy quantification and first explicit revenue synergy realization commentary (Q3 FY2026 earnings, August 2026) — look for $15–20M synergy contribution in P&L
• ◆6G sub-THz revenue breakout with first management disclosure of 6G-specific revenue contribution or discrete customer announcement (H2 FY2026–H1 FY2027) — monitor for sub-THz instrument order commentary and '6G' as revenue category
• ◆China export control clarity via BIS rulemaking (ongoing; binary event) — monitor BIS Federal Register for any new control framework affecting sub-THz instruments above 67 GHz
• ◆FY2027 guidance initiation at analyst day with multi-year targets incorporating Spirent at scale (FY2026 annual earnings / Analyst Day, December 2026) — this is the consensus reset event

• ◆Cyclical re-stall: AI capex pause + no 6G bridge; deferred capex thesis confirmed (30–40% probability over 3 years). Revenue -8–12%; EPS -30–40%; multiple compresses to 18x. Key signal: book-to-bill <0.9x for 2 consecutive quarters; hyperscaler capex guidance cuts.
• ◆China export controls expansion: sub-THz instruments added to EAR Entity List or Appendix controls (40–50% probability). $750M–$1.0B revenue at risk (15–20% of total); no short-term offset. Monitor BIS Federal Register and KEYS China revenue % trend.
• ◆Spirent integration disappointment: subscription churn, cross-sell miss, margin dilution, goodwill impairment (25–35% probability). $100–200M synergy miss; GAAP margin stuck at 15–17%; impairment charge risk. Watch Spirent revenue YoY, GAAP operating margin trajectory, and intangible amortization schedule.
• ◆Tariff cost escalation: $75–100M annual headwind persists or worsens (active exposure). 6–8% operating income headwind; supply chain disruption. Monitor management tariff commentary and gross margin trend.
• ◆Multiple compression independent of earnings: macro risk-off, rate cycle, or growth stock de-rating (20–30% probability over 2 years). -20–30% price impact even without EPS cut (22–25x → 18x). Watch macro rate environment and growth stock benchmark multiples.